Cargando…
Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box
Plasmodium falciparum thioredoxin reductase (PfTrxR) has been identified as a potential drug target to combat growing antimalarial drug resistance. Medicines for Malaria Venture (MMV) has pre-screened and identified a set of 400 antimalarial compounds called the Malaria Box. From those, we have eval...
Autores principales: | Tiwari, Neil K., Reynolds, Priscilla J., Calderón, Angela I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273446/ https://www.ncbi.nlm.nih.gov/pubmed/27043496 http://dx.doi.org/10.3390/molecules21040424 |
Ejemplares similares
-
Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery
por: McCarty, Sara E., et al.
Publicado: (2015) -
Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
por: Munigunti, Ranjith, et al.
Publicado: (2013) -
Identification and Functional Validation of the Novel Antimalarial
Resistance Locus PF10_0355 in Plasmodium
falciparum
por: Van Tyne, Daria, et al.
Publicado: (2011) -
Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates
por: Chirawurah, Jersley D., et al.
Publicado: (2017) -
A Mechanistic Investigation of the C-Terminal Redox Motif of Thioredoxin Reductase from Plasmodium falciparum
por: Snider, Gregg W., et al.
Publicado: (2014)